Istituti Fisioterapici Ospitalieri

Roma 144

2 studies enrolling now · 6 studies all time

What they study most

Breast Neoplasms, Follicular Lymphoma (FL), Marginal Zone Lymphoma, NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Non Hodgkin Lymphoma, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Pancreatic Cancer Harboring NRG1 Fusion, Pyoderma Gangrenosum, Solid Tumours Harboring NRG1 Fusion

Studies at this site

• A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum — Recruiting now
• Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations — Recruiting now
• Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1) — Running, not enrolling
• A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy) — Running, not enrolling
• A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2) — Completed
• Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL) — Stopped early